{"doi":"10.1056/nejmoa0912217","title":"Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer","abstract":"<h4>Background</h4>Oropharyngeal squamous-cell carcinomas caused by human papillomavirus (HPV) are associated with favorable survival, but the independent prognostic significance of tumor HPV status remains unknown.<h4>Methods</h4>We performed a retrospective analysis of the association between tumor HPV status and survival among patients with stage III or IV oropharyngeal squamous-cell carcinoma who were enrolled in a randomized trial comparing accelerated-fractionation radiotherapy (with acceleration by means of concomitant boost radiotherapy) with standard-fractionation radiotherapy, each combined with cisplatin therapy, in patients with squamous-cell carcinoma of the head and neck. Proportional-hazards models were used to compare the risk of death among patients with HPV-positive cancer and those with HPV-negative cancer.<h4>Results</h4>The median follow-up period was 4.8 years. The 3-year rate of overall survival was similar in the group receiving accelerated-fractionation radiotherapy and the group receiving standard-fractionation radiotherapy (70.3% vs. 64.3%; P=0.18; hazard ratio for death with accelerated-fractionation radiotherapy, 0.90; 95% confidence interval [CI], 0.72 to 1.13), as were the rates of high-grade acute and late toxic events. A total of 63.8% of patients with oropharyngeal cancer (206 of 323) had HPV-positive tumors; these patients had better 3-year rates of overall survival (82.4%, vs. 57.1% among patients with HPV-negative tumors; P<0.001 by the log-rank test) and, after adjustment for age, race, tumor and nodal stage, tobacco exposure, and treatment assignment, had a 58% reduction in the risk of death (hazard ratio, 0.42; 95% CI, 0.27 to 0.66). The risk of death significantly increased with each additional pack-year of tobacco smoking. Using recursive-partitioning analysis, we classified our patients as having a low, intermediate, or high risk of death on the basis of four factors: HPV status, pack-years of tobacco smoking, tumor stage, and nodal stage.<h4>Conclusions</h4>Tumor HPV status is a strong and independent prognostic factor for survival among patients with oropharyngeal cancer. (ClinicalTrials.gov number, NCT00047008.)","journal":"New England Journal of Medicine","year":2010,"id":2903,"datarank":18.782944681999172,"base_score":8.774003600200931,"endowment":8.774003600200931,"self_citation_contribution":1.3161005400301398,"citation_network_contribution":17.466844141969034,"self_endowment_contribution":1.3161005400301398,"citer_contribution":17.466844141969034,"corpus_percentile":91.3,"corpus_rank":1938,"citation_count":6463,"citer_count":167,"citers_with_citation_signal":167,"citers_with_endowment":167,"datacite_reuse_total":0,"is_dataset":false,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2010-07-01","authors":[{"id":32350,"name":"Jonathan Harris","orcid":"0000-0002-2953-4802","position":1,"is_corresponding":false},{"id":32351,"name":"Richard Wheeler","orcid":"0000-0002-9249-2377","position":2,"is_corresponding":false},{"id":32352,"name":"Randal Weber","orcid":null,"position":3,"is_corresponding":false},{"id":32353,"name":"David I. Rosenthal","orcid":"0000-0001-7124-7447","position":4,"is_corresponding":false},{"id":32354,"name":"Phuc Felix Nguyen-Tân","orcid":null,"position":5,"is_corresponding":false},{"id":24645,"name":"William H. Westra","orcid":null,"position":6,"is_corresponding":false},{"id":32355,"name":"Christine H. Chung","orcid":"0000-0001-5199-4306","position":7,"is_corresponding":false},{"id":32356,"name":"Richard C. Jordan","orcid":"0000-0002-2558-0537","position":8,"is_corresponding":false},{"id":18420,"name":"Charles Lu","orcid":"0000-0003-3450-1682","position":9,"is_corresponding":false},{"id":32357,"name":"Harold Kim","orcid":"0000-0002-0497-844X","position":10,"is_corresponding":false},{"id":32358,"name":"Rita Axelrod","orcid":"0009-0003-5740-0021","position":11,"is_corresponding":false},{"id":32359,"name":"C. Craig Silverman","orcid":null,"position":12,"is_corresponding":false},{"id":32360,"name":"Kevin P. Redmond","orcid":null,"position":13,"is_corresponding":false},{"id":32361,"name":"Maura L. Gillison","orcid":"0000-0002-8145-5749","position":14,"is_corresponding":false},{"id":32362,"name":"Randal S. Weber","orcid":"0000-0002-1980-7248","position":15,"is_corresponding":false},{"id":32363,"name":"Phuc Félix Nguyen‐Tan","orcid":null,"position":16,"is_corresponding":false},{"id":32349,"name":"K. Kian Ang","orcid":null,"position":0,"is_corresponding":true}],"reference_count":33,"raw_metadata":{"citation_network_status":"fetched"},"created_at":"2026-03-01T18:20:47.508186Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}